Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Drugs Controller General of India Dr VG Somani gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country.

from NDTV News - Latest https://ift.tt/2Rxkbqa

Comments

Popular posts from this blog

"Modi Does What He Promises": PM On Why People Trust His 'Guarantees'

'800-Strong Mob Intended To Cause Death': Probe Agency On Bengal Attack